Literature DB >> 31958087

Late-Life Cognitive Trajectories and their Associated Lifestyle Factors.

Junhong Yu1, Qiushi Feng2, Jintai Yu3, Yi Zeng4,5, Lei Feng1,6.   

Abstract

Significant variability exists in the trajectories of late-life cognitive decline; however, their associated lifestyle factors remain less studied. We examined these trajectories among elderly participants from the recent five waves (at three-year intervals) of the Chinese Longitudinal Healthy Longevity Study (CLHLS) from 2002 to 2014. Participants from this cohort were included if they completed at least four waves of measurements. Mini-Mental State Examination (MMSE) scores, demographics, medical diagnoses (e.g., hypertension, diabetes, and heart disease), and lifestyle-related information (e.g., smoking, drinking alcohol, and exercise) were collected from participants (N = 2,584; mean age at baseline = 73.3) at least four times across 12 years. MMSE scores were entered into a latent class mixed model analysis. Subsequently, demographic, medical, and lifestyle predictors were entered into multinomial logistic regression models to predict the trajectories. One of the four emerged classes (no decline) was characterized by an absence of cognitive decline; the other three exhibited various degrees of cognitive decline. The inclusion of lifestyle factors significantly improved the prediction of the different trajectories, above and beyond demographics and medical variables; the 'no decline' class was significantly more likely to report exercising regularly. Changes in cognitive functioning across the late-life period are characterized by multiple trajectories. Cognitive decline is not inevitable across the late-life period; the absence of such cognitive decline is partly explained by certain lifestyle factors.

Entities:  

Keywords:  Cognitive aging; cognitive function; exercise; late-life; latent class zzm321990mixed model; lifestyle

Year:  2020        PMID: 31958087      PMCID: PMC8082094          DOI: 10.3233/JAD-191058

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  30 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies.

Authors:  G Cheng; C Huang; H Deng; H Wang
Journal:  Intern Med J       Date:  2012-05       Impact factor: 2.048

3.  Cognitive decline in the elderly: an analysis of population heterogeneity.

Authors:  Kathleen M Hayden; Bruce R Reed; Jennifer J Manly; Douglas Tommet; Robert H Pietrzak; Gordon J Chelune; Frances M Yang; Andrew J Revell; David A Bennett; Richard N Jones
Journal:  Age Ageing       Date:  2011-09-02       Impact factor: 10.668

4.  Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.

Authors:  Rachel F Buckley; Elizabeth C Mormino; Rebecca E Amariglio; Michael J Properzi; Jennifer S Rabin; Yen Ying Lim; Kathryn V Papp; Heidi I L Jacobs; Samantha Burnham; Bernard J Hanseeuw; Vincent Doré; Annette Dobson; Colin L Masters; Michael Waller; Christopher C Rowe; Paul Maruff; Michael C Donohue; Dorene M Rentz; Dylan Kirn; Trey Hedden; Jasmeer Chhatwal; Aaron P Schultz; Keith A Johnson; Victor L Villemagne; Reisa A Sperling
Journal:  Alzheimers Dement       Date:  2018-05-24       Impact factor: 21.566

5.  Morphometric and histologic substrates of cingulate integrity in elders with exceptional memory capacity.

Authors:  Tamar Gefen; Melanie Peterson; Steven T Papastefan; Adam Martersteck; Kristen Whitney; Alfred Rademaker; Eileen H Bigio; Sandra Weintraub; Emily Rogalski; M-Marsel Mesulam; Changiz Geula
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

6.  High prevalence of mild cognitive impairment in the elderly: a community-based study in four cities of the Hebei province, china.

Authors:  Shunjiang Xu; Bing Xie; Mei Song; Lulu Yu; Lan Wang; Cuixia An; Qifeng Zhu; Keyan Han; Xiaochuan Zhao; Rui Zhang; Ling Dong; Ning Chai; Yuanyuan Gao; Qingfu Zhang; Xueyi Wang
Journal:  Neuroepidemiology       Date:  2014-01-28       Impact factor: 3.282

Review 7.  Tobacco as a social currency: cigarette gifting and sharing in China.

Authors:  Zachary C Rich; Shuiyuan Xiao
Journal:  Nicotine Tob Res       Date:  2011-08-17       Impact factor: 4.244

8.  Residual decline in cognition after adjustment for common neuropathologic conditions.

Authors:  Lei Yu; Patricia A Boyle; Eisuke Segawa; Sue Leurgans; Julie A Schneider; Robert S Wilson; David A Bennett
Journal:  Neuropsychology       Date:  2014-12-15       Impact factor: 3.295

9.  Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort.

Authors:  Anne B Newman; Annette L Fitzpatrick; Oscar Lopez; Sharon Jackson; Constantine Lyketsos; William Jagust; Diane Ives; Steven T Dekosky; Lewis H Kuller
Journal:  J Am Geriatr Soc       Date:  2005-07       Impact factor: 5.562

10.  Longitudinal trajectories of cognitive change in preclinical Alzheimer's disease: a growth mixture modeling analysis.

Authors:  Brent J Small; Lars Bäckman
Journal:  Cortex       Date:  2007-10       Impact factor: 4.027

View more
  2 in total

1.  Functional aging trajectories of older cancer survivors: a latent growth analysis of the US Health and Retirement Study.

Authors:  Ashly C Westrick; Kenneth M Langa; Marisa Eastman; Monica Ospina-Romero; Megan A Mullins; Lindsay C Kobayashi
Journal:  J Cancer Surviv       Date:  2022-02-26       Impact factor: 4.062

2.  Differences in Trajectories and Predictive Factors of Cognition over Time in a Sample of Cognitively Healthy Adults, in Zaragoza, Spain.

Authors:  Elena Lobo; Patricia Gracia-García; Antonio Lobo; Pedro Saz; Concepción De-la-Cámara
Journal:  Int J Environ Res Public Health       Date:  2021-07-02       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.